Sign in

CIK 0001863127

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tyra Biosciences, Inc.

Sign in to watch
Ticker
TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831476348
Phone
+1 619-728-4760
Business address
2656 STATE STREET, CARLSBAD, CA, 92008
Open-market buys, last 90 days
$20,000
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Verjee Rehan +$20K Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-09-15 Fuhrman Alan Chief Financial Officer Grant or award +951 $9.13 $9K 37,115
2026-05-05 Fuhrman Alan Chief Financial Officer Grant or award +20,000 36,164
2026-05-05 Fuhrman Alan Chief Financial Officer Grant or award · Stock Option (Right to Buy) +67,000 67,000
2026-03-13 Fuhrman Alan Chief Financial Officer Grant or award +1,376 $9.13 $13K 16,164
2025-09-15 Fuhrman Alan Chief Financial Officer Grant or award +701 $9.13 $6K 14,788
2025-08-07 Fuhrman Alan Chief Financial Officer Grant or award · Stock Option (Right to Buy) +170,000 170,000
2025-03-14 Fuhrman Alan Chief Financial Officer Grant or award +1,238 $9.78 $12K 14,087
2024-10-30 Fuhrman Alan Chief Financial Officer Purchase +9,500 $16.00 $152K 12,849
2024-09-13 Fuhrman Alan Chief Financial Officer Grant or award +954 $12.48 $12K 3,349
2024-08-14 Fuhrman Alan Chief Financial Officer Grant or award · Stock Option (Right to Buy) +115,000 115,000
2024-03-15 Fuhrman Alan Chief Financial Officer Grant or award +932 $12.48 $12K 2,395
2023-09-15 Fuhrman Alan Chief Financial Officer Grant or award +1,463 $12.50 $18K 1,463
2023-07-28 Fuhrman Alan Chief Financial Officer Grant or award · Stock Option (Right to Buy) +62,685 62,685
2023-01-01 Fuhrman Alan Chief Financial Officer Grant or award · Stock Option (Right to Buy) +32,800 32,800
2023-01-01 Fuhrman Alan Chief Financial Officer Grant or award · Stock Option (Right to Buy) +328,000 328,000

Page 1 of 1 · 15 trades